Clindamycin Phosphate Topical Solution USP 1%

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved July 1997

Specific Treatments:

acne vulgaris

Therapeutic Areas

Find Related Trials for The Following Conditions

General Information

Morton Grove Pharmaceuticals' Clindamycin Phosphate Topical Solution USP 1%, an antibiotic for the treatment of acne vulgaris, has been approved by the FDA. According to the FDA approval letter, Morton Grove Pharmaceuticals' product was found to be equivalent to CLEOCIN Topical Solution 1%, marketed by Pharmacia & Upjohn Company.